Co-amoxiclav 875mg/125mg Film-coated Tablets
Authorisation PA23148/004/003 · Brown & Burk IR Limited
- Licence holder
- Brown & Burk IR Limited (all products →)
- Active substances
- Amoxicillin, Clavulanic acid
- Clinical trials
- 30 clinical trials →
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC codes
- J01CA, J01CA04
- First authorised
- 09/03/2012
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Amoxicillin: supply and approvals
40 authorised products on the HPRA list contain Amoxicillin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- Amoxicillin and amoxicillin/clavulanic acid: Shortage resolved, first published 27 Jan 2023
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- 3 supply notices, e.g. Amoxicillin AL TS (1 May 2024 to 1 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Clavulanic acid: supply and approvals
25 authorised products on the HPRA list contain Clavulanic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- Amoxicillin and amoxicillin/clavulanic acid: Shortage resolved, first published 27 Jan 2023
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 14 years (since 9 March 2012). The HPRA list marks it as marketed in Ireland.
Other medicines with Amoxicillin in Ireland
35 other products on the HPRA list contain Amoxicillin, from 13 licence holders; 28 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Amoclav 500mg/125mg Film-coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Amoxicillin 250 mg hard capsules | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amoxicillin 250 mg/5 ml powder for oral suspension | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amoxicillin 500 mg hard capsules | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amoxicillin Delbert 500 mg powder for solution for injection or infusion | Laboratoires DELBERT | National authorisation (PA) | Marketed |
| Augmentin 250 mg/125 mg film-coated tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin 500 mg/125 mg film-coated tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin 875 mg/125 mg film-coated tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Clavamel Forte 500mg/125mg film-coated tablet | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral Suspension | Brown & Burk IR Limited | National authorisation (PA) | Marketed |
Other medicines with Clavulanic acid in Ireland
24 other products on the HPRA list contain Clavulanic acid, from 11 licence holders; 20 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Amoclav 500mg/125mg Film-coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Augmentin 250 mg/125 mg film-coated tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin 500 mg/125 mg film-coated tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin 875 mg/125 mg film-coated tablets | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Clavamel Forte 500mg/125mg film-coated tablet | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral Suspension | Brown & Burk IR Limited | National authorisation (PA) | Marketed |
| Co-Amoxiclav TEVA 1000 mg/200 mg Powder for Solution for Injection/Infusion | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Co-Amoxiclav TEVA 500 mg/100 mg Powder for Solution for Injection/Infusion | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Co-amoxiclav 1000 mg/200 mg powder for solution for injection/infusion | Instituto Biochimico Italiano G. Lorenzini S.p.A. | National authorisation (PA) | Marketed |
| Co-amoxiclav 1000mg/200mg powder for solution for injection/infusion | Fresenius Kabi Deutschland GmbH | National authorisation (PA) | Marketed |
Other substances in ATC group J01CA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group J01CA with this product:
Amoxicillin (as trihydrate) (1) · Pivmecillinam hydrochloride (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Brown & Burk IR Limited holds 15 products on the HPRA list, with 10 different active substances; 9 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.